These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36765687)

  • 1. Is Reflex Germline
    Morgan RD; Burghel GJ; Flaum N; Bulman M; Smith P; Clamp AR; Hasan J; Mitchell CL; Salih Z; Woodward ER; Lalloo F; Crosbie EJ; Edmondson RJ; Schlecht H; Jayson GC; Evans DGR
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Concordance between Germline and Tumour
    Morgan RD; Burghel GJ; Schlecht H; Clamp AR; Hasan J; Mitchell CL; Salih Z; Shaw J; Desai S; Jayson GC; Woodward ER; Evans DGR
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the likelihood of a
    Morgan RD; Burghel GJ; Flaum N; Bulman M; Smith P; Clamp AR; Hasan J; Mitchell C; Salih Z; Woodward ER; Lalloo F; Shaw J; Desai S; Crosbie EJ; Edmondson RJ; Schlecht H; Wallace AJ; Jayson GC; Evans DGR
    J Clin Pathol; 2023 Oct; 76(10):684-689. PubMed ID: 35738887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?
    Morgan RD; Burghel GJ; Flaum N; Bulman M; Smith P; Clamp AR; Hasan J; Mitchell CL; Salih Z; Woodward ER; Lalloo F; Crosbie EJ; Edmondson RJ; Wallace AJ; Jayson GC; Evans DGR
    Br J Cancer; 2022 Jul; 127(1):163-167. PubMed ID: 35260807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.
    Richau CS; Scherer NM; Matta BP; de Armas EM; de Barros Moreira FC; Bergmann A; Pereira Chaves CB; Boroni M; Dos Santos ACE; Moreira MAM
    Cancer Med; 2024 Feb; 13(3):e6729. PubMed ID: 38308422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England.
    Flaum N; Morgan RD; Burghel GJ; Bulman M; Clamp AR; Hasan J; Mitchell CL; Badea D; Moon S; Hogg M; Hadjiyiannakis D; Clancy T; Schlecht H; Woodward ER; Crosbie EJ; Edmondson RJ; Wallace AJ; Jayson GC; Lalloo FI; Harkness EF; Evans DGR
    Eur J Hum Genet; 2020 Nov; 28(11):1541-1547. PubMed ID: 32651552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high-grade serous ovarian cancer: a national retrospective audit.
    Frugtniet B; Morgan S; Murray A; Palmer-Smith S; White R; Jones R; Hanna L; Fuller C; Hudson E; Mullard A; Quinton AE
    BJOG; 2022 Feb; 129(3):433-442. PubMed ID: 34657373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study.
    Morgan RD; Clamp AR; Barnes BM; Timms K; Schlecht H; Yarram-Smith L; Wallis Y; Valganon-Petrizan M; MacMahon S; White R; Morgan S; McKenna S; Hudson E; Tookman L; George A; Manchanda R; Sundar SS; Nicum S; Brenton JD; Kristeleit RS; Banerjee S; McNeish IA; Ledermann JA; Taylor SS; Evans DGR; Jayson GC
    Int J Gynecol Cancer; 2023 Aug; 33(8):1253-1259. PubMed ID: 37072323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non-high-grade serous ovarian carcinomas.
    Kramer C; Lanjouw L; Ruano D; Ter Elst A; Santandrea G; Solleveld-Westerink N; Werner N; van der Hout AH; de Kroon CD; van Wezel T; Berger L; Jalving M; Wesseling J; Smit V; de Bock GH; van Asperen CJ; Mourits M; Vreeswijk M; Bart J; Bosse T
    J Pathol; 2024 Feb; 262(2):137-146. PubMed ID: 37850614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Testing for Somatic and Germline
    Peixoto A; Pinto P; Guerra J; Pinheiro M; Santos C; Pinto C; Santos R; Escudeiro C; Bartosch C; Canário R; Barbosa A; Gouveia A; Petiz A; Abreu MH; Sousa S; Pereira D; Silva J; Teixeira MR
    Front Oncol; 2020; 10():1318. PubMed ID: 32850417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over.
    Pitiyarachchi O; Ansell PJ; Coleman RL; Dinh MH; Holman L; Leath CA; Werner T; DiSilvestro P; Morgan M; Tew W; Lee C; Cunningham M; Newton M; Edraki B; Lim P; Barlin J; Spirtos NM; Tewari KS; Edelson M; Reid T; Carlson J; Friedlander M
    Gynecol Oncol; 2024 Aug; 187():221-226. PubMed ID: 38821039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women.
    Filippova OT; Selenica P; Pareja F; Vahdatinia M; Zhu Y; Pei X; Riaz N; Long Roche K; Chi DS; Abu-Rustum NR; Ellenson LH; Reis-Filho JS; Zamarin D; Weigelt B
    Gynecol Oncol; 2021 May; 161(2):545-552. PubMed ID: 33674143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the Diagnostic Yield of Tumour Testing and Qualifying Germline Concordance for Hereditary Cancer Variants in Patients with High-Grade Serous Carcinoma.
    Goebel EA; Kerkhof J; Dzyubak O; McLachlin CM; McGee J; Sadikovic B
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD).
    Incorvaia L; Badalamenti G; Novo G; Gori S; Cortesi L; Brando C; Cinieri S; Curigliano G; Ricciardi GR; Toss A; Chiari R; Berardi R; Ballatore Z; Bono M; Bazan Russo TD; Gristina V; Galvano A; Damerino G; Blasi L; Bazan V; Russo A
    ESMO Open; 2024 Jan; 9(1):102196. PubMed ID: 38118367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in
    Stegel V; Blatnik A; Škof E; Dragoš VŠ; Krajc M; Gregorič B; Škerl P; Strojnik K; Klančar G; Banjac M; Žgajnar J; Ravnik M; Novaković S
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes.
    Olmos D; Lorente D; Alameda D; Cattrini C; Romero-Laorden N; Lozano R; Lopez-Casas PP; Jambrina A; Capone C; Vanden Broecke AM; Trevisan M; Van Sanden S; Jürgens A; Herrera-Imbroda B; Castro E
    Ann Oncol; 2024 May; 35(5):458-472. PubMed ID: 38417742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.
    Golan T; O'Kane GM; Denroche RE; Raitses-Gurevich M; Grant RC; Holter S; Wang Y; Zhang A; Jang GH; Stossel C; Atias D; Halperin S; Berger R; Glick Y; Park JP; Cuggia A; Williamson L; Wong HL; Schaeffer DF; Renouf DJ; Borgida A; Dodd A; Wilson JM; Fischer SE; Notta F; Knox JJ; Zogopoulos G; Gallinger S
    Gastroenterology; 2021 May; 160(6):2119-2132.e9. PubMed ID: 33524400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
    Konstantinopoulos PA; Norquist B; Lacchetti C; Armstrong D; Grisham RN; Goodfellow PJ; Kohn EC; Levine DA; Liu JF; Lu KH; Sparacio D; Annunziata CM
    J Clin Oncol; 2020 Apr; 38(11):1222-1245. PubMed ID: 31986064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer.
    Pierre ME; Manneh R; Hernández A; Rodríguez J; Fletcher AV; Ramírez HM; Niño OM; Gómez DA; Sanabria D; Contreras F; Pieschacón JR; Calderón PH
    Rev Colomb Obstet Ginecol; 2024 Jun; 75(1):. PubMed ID: 39013199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model.
    Azzollini J; Vingiani A; Agnelli L; Tamborini E; Perrone F; Conca E; Capone I; Busico A; Peissel B; Rosina E; Ducceschi M; Mantiero M; Lopez S; Raspagliesi F; Niger M; Duca M; Damian S; Proto C; de Braud F; Pruneri G; Manoukian S
    Front Oncol; 2022; 12():857515. PubMed ID: 35463374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.